Journal article icon

Journal article

PATHWAY-2: spironolactone for resistant hypertension

Subtitle:
Correspondence
Abstract:
We have identified discrepancies in the Article by Williams and colleagues between prespecified and reported outcomes.
Publication status:
Published
Peer review status:
Not peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care; Primary Care Health Sciences
Oxford college:
Somerville College
Role:
Author
ORCID:
0000-0002-5127-4728
Publisher:
Elsevier Publisher's website
Journal:
Lancet Journal website
Volume:
387
Issue:
10026
Pages:
1372-1373
Publication date:
2016-04-02
Acceptance date:
2016-04-02
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
Pubs id:
pubs:618766
URN:
uri:ef5362cc-1511-4822-942f-54ac56b5116a
UUID:
uuid:ef5362cc-1511-4822-942f-54ac56b5116a
Local pid:
pubs:618766
Paper number:
10026
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP